UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Ventoline2mgmllosningnebulisator-SE-PLC-MPD-BBDL

Ventoline 2 mg/ml lösning för nebulisator

MPID: SE-100000307-00011088
EURDID: 10330

Full name: Ventoline 2 mg/ml lösning för nebulisator

- Invented name part: Ventoline

- Strength part: 2 mg/ml

- Pharmaceutical dose form part: lösning för nebulisator

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Nebuliser solution

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000098065 salbutamol

Marketing Authorisation 1 of 1

Authorisation number: 11088

Region: Kingdom of Sweden

Marketing authorisation holder: GlaxoSmithKline AB

Identifier:

  • LOC-100000549

Status: Valid (1990-02-02)

Package 1 of 1

PCID:

Description:
Endosbehållare 6 x 10 x 2,5 ml

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 60 Pipette

Package: 1 Box (Cardboard)

Containing:

Package: 6 Pouch (Aluminium)

Containing: 60 Pipette

Manufactured Item

Dose form: Nebuliser solution

Unit of presentation: Pipette

Ingredient

Role: Active

Substance: Salbutamol sulfate

Concentration strength: 2.4 milligram(s) / 1 millilitre(s)

Reference strength:
salbutamol 2 milligram(s) / 1 millilitre(s)

Administrable Product (1 of 1)

Dose form: Nebuliser solution

Unit of presentation:

Route of administration:

  • Inhalation use

Ingredients:

Ingredient

Role: Active

Substance: Salbutamol sulfate

Concentration strength: 2.4 milligram(s) / 1 millilitre(s)

Reference strength:
salbutamol 2 milligram(s) / 1 millilitre(s)